celecoxib has been researched along with Pneumonia, Viral in 1 studies
Pneumonia, Viral: Inflammation of the lung parenchyma that is caused by a viral infection.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carprofen and Celecoxib have been selected by the COVID Moonshot initiative for in vitro testing; they show 3." | 1.56 | Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition. ( Cereto-Massagué, A; Garcia-Vallvé, S; Gimeno, A; Macip, G; Mestres-Truyol, J; Ojeda-Montes, MJ; Pujadas, G; Saldivar-Espinoza, B, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gimeno, A | 1 |
| Mestres-Truyol, J | 1 |
| Ojeda-Montes, MJ | 1 |
| Macip, G | 1 |
| Saldivar-Espinoza, B | 1 |
| Cereto-Massagué, A | 1 |
| Pujadas, G | 1 |
| Garcia-Vallvé, S | 1 |
1 other study available for celecoxib and Pneumonia, Viral
| Article | Year |
|---|---|
Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition.
Topics: Antiviral Agents; Betacoronavirus; Binding Sites; Carbazoles; Celecoxib; Coronavirus Infections; COV | 2020 |